Miciaccia, M.; Rizzo, F.; Centonze, A.; Cavallaro, G.; Contino, M.; Armenise, D.; Baldelli, O.M.; Solidoro, R.; Ferorelli, S.; Scarcia, P.;
et al. Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. Pharmaceuticals 2024, 17, 135.
https://doi.org/10.3390/ph17010135
AMA Style
Miciaccia M, Rizzo F, Centonze A, Cavallaro G, Contino M, Armenise D, Baldelli OM, Solidoro R, Ferorelli S, Scarcia P,
et al. Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. Pharmaceuticals. 2024; 17(1):135.
https://doi.org/10.3390/ph17010135
Chicago/Turabian Style
Miciaccia, Morena, Francesca Rizzo, Antonella Centonze, Gianfranco Cavallaro, Marialessandra Contino, Domenico Armenise, Olga Maria Baldelli, Roberta Solidoro, Savina Ferorelli, Pasquale Scarcia,
and et al. 2024. "Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment" Pharmaceuticals 17, no. 1: 135.
https://doi.org/10.3390/ph17010135
APA Style
Miciaccia, M., Rizzo, F., Centonze, A., Cavallaro, G., Contino, M., Armenise, D., Baldelli, O. M., Solidoro, R., Ferorelli, S., Scarcia, P., Agrimi, G., Zingales, V., Cimetta, E., Ronsisvalle, S., Sipala, F. M., Polosa, P. L., Fortuna, C. G., Perrone, M. G., & Scilimati, A.
(2024). Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. Pharmaceuticals, 17(1), 135.
https://doi.org/10.3390/ph17010135
